Biopharma Co. Misled Investors On Cancer Drug Progress: Suit
Vical Inc., which researches and develops biopharmaceutical products for the prevention and treatment of serious diseases, on Wednesday was hit with a putative class action in California federal court by a...To view the full article, register now.
Already a subscriber? Click here to view full article